CAMPBELL, Calif. , Oct. 28, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical devices and software to combat chronic diseases, today announced that due to its pending transaction with Strive, Inc., the company will not be hosting a conference call or providing an accompanying earnings presentation in... Read More

DALLAS, TX and CAMPBELL, CA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Strive, Inc . (“Strive”) entered into a definitive agreement to acquire Semler Scientific, Inc. (“Semler Scientific”) in an all-stock transaction. In addition, Strive announced the purchase of 5,816 Bitcoin to its corporate treasury at an average price of $116,047 per Bitcoin, for a total purchase price of $675,000,000, inclusive of fees and expenses, bringing... Read More

CAMPBELL, Calif. , Aug. 4, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin , today reported financial results for the second quarter ended June 30, 2025 and provided an update on its Bitcoin holdings and other key performance indicators (KPIs). "We have made excellent... Read More

CAMPBELL, Calif. , July 21, 2025 /PRNewswire/ - -Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical devices and software to combat chronic diseases, today announced it will report financial results for the second quarter ended June 30, 2025 , after the close of U.S. financial markets on Monday, August 4, 2025 . Doug... Read More

CAMPBELL, Calif. , June 24, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset and a leader in medical device and software to combat chronic diseases, announced that it has formed CardioVanta, Inc., a wholly-owned subsidiary that will comprise its future healthcare business activities focused on early detection of heart failure... Read More

CAMPBELL, Calif. , June 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin , announced the appointment of Joe Burnett as director of Bitcoin strategy. Semler Scientific also announced that it plans to hold 10,000 Bitcoins by year-end 2025, 42,000 by year-end 2026 and... Read More

CAMPBELL, Calif. , May 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin , announced the appointment of Natalie Brunell to its board of directors. This strategic addition reflects Semler Scientific's continued commitment to its Bitcoin treasury strategy and further... Read More

CAMPBELL, Calif. , May 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin , today reported financial results for the first quarter ended March 31, 2025 and provided an update on its bitcoin holdings and other key performance indicators (KPIs). "We continue to... Read More

SANTA CLARA, Calif. , April 30, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin , today announced updates regarding its bitcoin (BTC) activity, holdings and yield, its at-the-market equity offering (ATM) program and first quarter earnings release date and conference... Read More

SANTA CLARA, Calif. , April 25, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to assist its customers in evaluating and treating chronic diseases, today announced updates regarding its bitcoin (BTC) activity, holdings and yield, as well as its at-the-market equity offering (ATM) programs. BTC Update Between February 14, 2025 and April 24,... Read More

SANTA CLARA, Calif. , Feb. 18, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the fourth quarter and year ended December 31, 2024 . "We are again pleased to report strong performance from our healthcare business with income from operations of $20.9... Read More

SANTA CLARA, Calif. , Feb. 4, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to assist its customers in evaluating and treating chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, and BTC Yield, a key performance indicator. BTC Update Between January 11, 2025 and February 3, 2025 , Semler Scientific... Read More

SANTA CLARA, Calif. , Jan. 24, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR) today announced the pricing of its offering of $85.0 million aggregate principal amount of 4.25% convertible senior notes due 2030 (the "notes") in a private offering (the "offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities... Read More

SANTA CLARA, Calif. , Jan. 23, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced select preliminary unaudited fourth quarter 2024 financial results and BTC holdings. Semler Scientific will report full financial results for the fourth quarter and full year ended December 31,... Read More

SANTA CLARA, Calif. , Jan. 23, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR) today announced that it intends to offer, subject to market conditions and other factors, $75.0 million aggregate principal amount of convertible senior notes due 2030 (the "notes") in a private offering (the "offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act... Read More

SANTA CLARA, Calif. , Jan. 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, capital markets activity, and BTC Yield, a key performance indicator. BTC Update Between December 16, 2024 and January 10, 2025 , Semler... Read More

SANTA CLARA, Calif. , Dec. 16, 2024 /PRNewswire/ -- Semler Scientific, Inc . (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, capital markets activity, and BTC Yield, a key performance indicator. BTC Update Between December 5, 2024 and December 15, 2024 , Semler... Read More

SANTA CLARA, Calif. , Dec. 5, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, capital markets activity, and BTC Yield, a key performance indicator. BTC Update Between November 25, 2024 and December 4, 2024 , Semler... Read More

Purchased Additional 297 BTC; Now Holds 1,570 BTC; BTC Yield of 58.4% Launches Additional $50.0 million ATM SANTA CLARA, Calif. , Nov. 25, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, capital markets activity, and... Read More

SANTA CLARA, Calif. , Nov. 4, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the third quarter ended September 30, 2024 . In addition, Semler Scientific announced the purchase of an additional 47 bitcoins for an aggregate amount of $3.0 million from... Read More

SANTA CLARA, Calif. , Oct. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it will report financial results for the third quarter and nine months ended September 30, 2024 , as well as provide an update on its Bitcoin holdings after the close of U.S. financial markets... Read More

SANTA CLARA, Calif. , Aug. 26, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it has purchased an additional 83 bitcoins for $5.0 million in cash, inclusive of fees and expenses. As of August 26, 2024 , Semler Scientific holds a total of 1,012 bitcoins, which were... Read More

SANTA CLARA, Calif. , Aug. 5, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the second quarter ended June 30, 2024 . In addition, the Company announced the purchase of an additional 101 bitcoins for an aggregate amount of $6.0 million . Since announcing... Read More

SANTA CLARA, Calif. , July 22, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced that it will report financial results for the second quarter and six months ended June 30, 2024 , after the close of U.S. financial markets on Monday, August 5, 2024 . Doug Murphy-Chutorian , M.D.,... Read More

SANTA CLARA, Calif. , May 28, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, announced today that its board of directors has adopted bitcoin as its primary treasury reserve asset. In addition, Semler Scientific announced that it has purchased 581 bitcoins for an aggregate amount of $40... Read More

2024 Q1 highlights compared to the corresponding period of 2023: First quarter revenues were $15.9 million , a decrease of 13% First quarter net income was $6.1 million , an increase of 22% Cash, cash equivalents and restricted cash balance increased to $62.9 million SANTA CLARA, Calif. , May 7, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical... Read More

SANTA CLARA, Calif. , April 23, 2024 /PRNewswire/ -- Semler Scientific, Inc . (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the first quarter ended March 31, 2024 , after the close of U.S. financial markets on Tuesday, May 7, 2024 . Doug... Read More

2023 Q4 and full year highlights compared to the corresponding period of 2022: Fourth quarter revenues were $15.1 million , an increase of 9% Fourth quarter net income was $4.2 million , an increase of 31% Full year revenues were $68.2 million , an increase of 20% Full year net income was $20.6 million , an increase of 44% Cash balance increased to $57.3 million SANTA CLARA, Calif. , March 5, 2024 /PRNewswire/ -- Semler... Read More

SANTA CLARA, Calif. , Feb. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 , after the close of U.S. financial markets on Tuesday, March 5, 2024.... Read More

20 23 Q3 highlights: Revenue of $16.3 million , an increase of 16% compared to the corresponding period of 2022 Net income of $5.5 million , an increase of 50% compared to the corresponding period of 2022 Quarter-ending cash, cash equivalents and short-term investments of $56.0 million SANTA CLARA, Calif. , Nov. 9, 2023 /PRNewswire/ -- Semler Scientific, Inc . (Nasdaq: SMLR), a company that develops, manufactures and markets... Read More

SANTA CLARA, Calif. , Oct. 26, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the third quarter and first nine months ended September 30, 2023 , after the close of U.S. financial markets on Thursday, November... Read More

SANTA CLARA, Calif. , Aug. 31, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced Renae Cormier , CFO, will participate in the following investor conference: Lake Street Capital Markets 7 th Annual Best Ideas Growth (BIG7) Conference Date: September 14,... Read More

2023 Q2 highlights: Revenue was $18.6 million , an increase of 25% compared to the corresponding period of 2022 Net income was $5.9 million , an increase of 44% compared to the corresponding period of 2022 Cash, cash equivalents and short-term investments of $51.8 million SANTA CLARA, Calif. , Aug. 10, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative... Read More

SANTA CLARA, Calif. , July 28, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it will report financial results for the second quarter ended June 30, 2023 , after the close of U.S. financial markets on Thursday, August 10, 2023 . Doug... Read More

SANTA CLARA, Calif. , July 11, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced the appointment of a chief financial officer (CFO), record quarterly revenues expected for the second quarter of 2023 and a strategic streamlining. "We are pleased to... Read More

SANTA CLARA, Calif. , June 23, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced that it is set to join the Russell 2000 ® and 3000 ® Indexes at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on... Read More

2023 Q1 highlights: Revenue was $18.2 million , an increase of 30% compared to the corresponding period of 2022 Net income was $5.0 million , an increase of 48% compared to the corresponding period of 2022 Cash, cash equivalents and short-term investments of $43.0 million SANTA CLARA, Calif. , May 10, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative... Read More

SANTA CLARA, Calif. , May 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended March 31, 2023 , after the close of U.S. financial markets on Wednesday, May 10, 2023 . Doug Murphy-Chutorian , M.D., interim chief... Read More

SANTA CLARA, Calif. , April 28, 2023 /PRNewswire/ -- The board of directors of Semler Scientific, Inc. (Nasdaq: SMLR), is pleased to announce that it has appointed Doug Murphy-Chutorian , M.D., former CEO and a current member of the board of directors as chief executive officer (CEO) on an interim basis with immediate effect. The board intends to conduct a global search for a permanent CEO. "We are delighted that Doug has... Read More

Eric Semler Appointed as Chairman SANTA CLARA, Calif. , April 19, 2023 /PRNewswire/ -- - Semler Scientific, Inc. (Nasdaq: SMLR) today announced that Eric Semler and William H.C. Chang (together, the "Investors"), who collectively beneficially own more than 20% of Semler Scientific's outstanding shares, will immediately join Semler Scientific's board of directors as new independent directors. Mr. Semler will join the board as... Read More

SANTA CLARA, Calif. , April 5, 2023 /PRNewswire/ -- Semler Scientific, Inc. ( Nasdaq : SMLR ), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Wayne T . Pan, Ph .D., M .D., and head of corporate communications and business strategy, Renae Cormier , will present a company overview at the 22nd Annual... Read More

SANTA CLARA, Calif. , April 3, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, commented on the recent Centers for Medicare and Medicaid Services (CMS) 2024 Medicare Advantage and Part D Final Rate Announcement. "Semler Scientific remains confident that screening for peripheral artery... Read More

2022 Q4 and Full Year highlights compared to the corresponding period of 2021: Fourth quarter revenue was $13.8 million , an increase of 20% Fourth quarter net income was $3.2 million , an increase of 113% Full year revenue was $56.7 million , an increase of 7% Full year net income was $14.3 million , a decrease of 17% Cash at December 31, 2022 increased to $43.1 million , including short-term investments Corporate update:... Read More

SANTA CLARA, Calif. , March 21, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, announces that Doug Murphy-Chutorian , M.D. has informed the board of directors of his intention to step down from his position as chief executive officer (CEO) of Semler Scientific and assist for a transition... Read More

SANTA CLARA, Calif. , March 10, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2022 , after the close of U.S. financial markets on Tuesday, March 21, 2023 . Doug Murphy-Chutorian ,... Read More

SANTA CLARA, Calif. , March 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers (HCPs), today announced the publication of a study in the peer-reviewed Journal of Preventive Medicine with data supporting the use of QuantaFlo as an aid to measure hemodynamics related to heart dysfunction (HD).... Read More

SANTA CLARA, Calif. , Dec. 14, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that a study was published in the peer-reviewed AJPM Focus with data collected using the company's QuantaFlo® PAD test under real-world conditions, illustrating the benefits of PAD in-home... Read More

SANTA CLARA, Calif. , Dec. 12, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced an up to $5.0 million investment in privately-held Monarch Medical Technologies, LLC (Monarch) through the purchase of a senior secured convertible promissory note. Repayment of the note is secured... Read More